GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Arbor Rapha Capital Bioholdings Corp I (NAS:ARCK) » Definitions » Net Margin %

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Net Margin % : 0.00% (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Arbor Rapha Capital Bioholdings I Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Arbor Rapha Capital Bioholdings I's Net Income for the three months ended in Sep. 2022 was $0.35 Mil. Arbor Rapha Capital Bioholdings I's Revenue for the three months ended in Sep. 2022 was $0.00 Mil. Therefore, Arbor Rapha Capital Bioholdings I's net margin for the quarter that ended in Sep. 2022 was 0.00%.

The historical rank and industry rank for Arbor Rapha Capital Bioholdings I's Net Margin % or its related term are showing as below:


ARCK's Net Margin % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 5.42
* Ranked among companies with meaningful Net Margin % only.

Arbor Rapha Capital Bioholdings I Net Margin % Historical Data

The historical data trend for Arbor Rapha Capital Bioholdings I's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbor Rapha Capital Bioholdings I Net Margin % Chart

Arbor Rapha Capital Bioholdings I Annual Data
Trend Dec21
Net Margin %
-

Arbor Rapha Capital Bioholdings I Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Net Margin % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Arbor Rapha Capital Bioholdings I's Net Margin %

For the Shell Companies subindustry, Arbor Rapha Capital Bioholdings I's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arbor Rapha Capital Bioholdings I's Net Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Arbor Rapha Capital Bioholdings I's Net Margin % distribution charts can be found below:

* The bar in red indicates where Arbor Rapha Capital Bioholdings I's Net Margin % falls into.



Arbor Rapha Capital Bioholdings I Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Arbor Rapha Capital Bioholdings I's Net Margin for the fiscal year that ended in Dec. 2021 is calculated as

Net Margin=Net Income (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=0/0
= %

Arbor Rapha Capital Bioholdings I's Net Margin for the quarter that ended in Sep. 2022 is calculated as

Net Margin=Net Income (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=0.35/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arbor Rapha Capital Bioholdings I  (NAS:ARCK) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Arbor Rapha Capital Bioholdings I Net Margin % Related Terms

Thank you for viewing the detailed overview of Arbor Rapha Capital Bioholdings I's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Business Description

Traded in Other Exchanges
N/A
Address
333 Earle Ovington Boulevard, Suite 900, Uniondale, NY, USA, 11553
Arbor Rapha Capital Bioholdings Corp I is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Ralph Mack director 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Kevin M. Slawin director, officer: Chief Strategy Officer C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON TX 77030
Ivan Kaufman director, 10 percent owner, officer: Chief Executive Officer
Arbor Commercial Mortgage Llc director, 10 percent owner, officer: Chief Executive Officer 333 EARLE OVINGTON BLVD, STE 900, UNIONDALE NY 11553
Paul Elenio officer: Chief Financial Officer C/O ARBOR REALTY TRUST, 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
John Natalone officer: Treasurer C/O ARBOR REALTY TRUST, INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
William P Connolly officer: Secretary & Vice President C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Cyrus D. Walker director C/O MARIPOSA CAPITAL, LLC, 500 SOUTH POINTE DRIVE, SUITE 240, MIAMI BEACH FL 33139
Arbor Rapha Capital Llc director, 10 percent owner, officer: Chief Executive Officer 333 EARLE OVINGTON BLVD., SUITE 900, UNIONDALE NY 11553
Avery Modlin director C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Headlines